alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2015205EN.01003301.xml

| 22.6.2015 | EN | Official Journal of the European Union | C 205/33 |
| --- | --- | --- | --- |

22.6.2015

EN

Official Journal of the European Union

C 205/33

---

Order of the General Court of 27 April 2015 —Vierling v OHIM — IP Leanware (BRAINCUBE)

(Case T-581/14) (1)

1

((Community trade mark - Opposition - Withdrawal of the opposition - No need to adjudicate))

(2015/C 205/44)

Language of the case: English

Parties

Parties

Applicant: Yvonne Vierling (Cologne, Germany) (represented by: G. Hasselblatt and D. Kipping, lawyers)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: I. Harrington, acting as Agent)

Defendant:

Other party to the proceedings before the Board of Appeal of OHIM: IP Leanware (Issoire, France)

Other party to the proceedings before the Board of Appeal of OHIM:

Re:

Re:

Action brought against the decision of the Second Board of Appeal of OHIM of 30 April 2014 (Case R 1486/2013-2) concerning opposition proceedings between Yvonne Vierling and IP Leanware.

Operative part of the order

Operative part of the order

| 1) | There is no longer any need to adjudicate on the action. |
| --- | --- |

1)

There is no longer any need to adjudicate on the action.

| 2) | Ms Yvonne Vierling shall bear her own costs and pay those incurred by OHIM. |
| --- | --- |

2)

Ms Yvonne Vierling shall bear her own costs and pay those incurred by OHIM.

---

(1)  OJ C 351, 6.10.2014.

1

---
SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 Current Report

                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934

                Date of Report (date of earliest event reported)

                                  June 16, 2003

                     MEDICAL STAFFING NETWORK HOLDINGS, INC.
             (Exact name of registrant as specified in its charter)

         Delaware                    1-31299                    06-0865171
         --------                    -------                    ----------
(State or other jurisdiction     (Commission File             (IRS Employer
     of incorporation)                Number)               Identification No.)

                901 Yamato Road, Suite 110, Boca Raton, FL 33431
                ------------------------------------------------
                    (Address of principal executive offices)

        Registrant's telephone number, including area code: 561-322-1300


<PAGE>

Item 7(c). Exhibits

99.1 Press Release dated June 16, 2003.

Item 9. Regulation FD Disclosure

      The registrant is attaching a copy of a press release dated June 16, 2003,
as Exhibit 99.1.

Limitation on Incorporation by Reference

      In accordance with general instruction B.2 of Form 8-K, the information in
this report (including the exhibit) is furnished pursuant to Item 9 and shall
not be deemed to be "filed" for the purposes of Section 18 of the Securities
Exchange Act of 1934, as amended or otherwise subject to liabilities of that
section. This report will not be deemed an admission as to the materiality of
any information in the report that is required to be disclosed solely by
Regulation FD.

<PAGE>

                                    SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date: June 16, 2003                     MEDICAL STAFFING NETWORK HOLDINGS, INC.

                                        By: /s/ Kevin S. Little
                                            -----------------------------
                                            Kevin S. Little
                                            Chief Financial Officer


                                       3

<PAGE>

                                  EXHIBIT INDEX

Exhibit No.       Description

99.1              Press release dated June 16, 2003


                                       4
#### Ax et al. *v.*Schloot et al.

[No. 17,416.

Filed December 14, 1945.]

[For opinion on merits, see post, p. 366.]

*304
      *John R. Ax,*of Huntingburg, and *Paid Haywood,*of Bloomfield, for appellants.

*Edwin B. Long*and *Beasley & Beasley,*all of Linton, and *Allen G. Pate,*of Bloomfield, for appellees.

Crumpacker, J.

This is an action in conversion instituted in the Greene Circuit Court by the appellants against the appellees. Trial was to a jury and at the close of the appellants’ case the court directed a verdict for the appellees which verdict the jury duly returned. The appellants thereupon filed a motion for a new trial which the court overruled and this appeal was perfected in due course. The transcript shows no judgment on such verdict and as it is certified as being a true and accurate copy of the record we assume there is none.

Rule 2-3, 1943 Revision provides: “No appeal will be dismissed as of right because the case was not finally disposed of in the court below as to all issues and parties, but upon suggestion or discovery of such a situation the appellate tribunal may, in its discretion suspend consideration until disposition is made of such issues. . . .” By virtue of this rule we have concluded to and do now suspend consideration of this appeal until such time as the Greene Circuit Court finally disposes of the issues involved in this case by the entry of an appropriate judgment on' the verdict of the jury. The clerk of the Greene Circuit Court is hereby ordered to certify a copy of such judgment, when entered, to the clerk of this court, and the same is hereby ordered to thereupon become a part of the transcript of the record heretofore filed in this appeal.

Note. — Reported in 64 N. E. (2d) 31.
EXHIBIT 32
----------




                           CERTIFICATIONS OF
          CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
                  PURSUANT TO 18 U.S.C. SECTION 1350,
               AS ADOPTED PURSUANT TO SECTION 906 OF THE
                      SARBANES-OXLEY ACT OF 2002
          ---------------------------------------------------



     The following statement is provided by the undersigned to accompany
the Quarterly Report on Form 10-Q for the quarter ended June 30, 2010,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be
deemed filed pursuant to any provision of the Securities Exchange Act of
1934 or any other securities law:

     Each of the undersigned certifies that the foregoing Report on
Form 10-Q fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934 (15 U.S.C. 78m) and that the information
contained in the Form 10-Q fairly presents, in all material respects, the
financial condition and results of operations of ALP Liquidating Trust.




                                       /s/   Gary Nickele
                                       ------------------------------
                                       Gary Nickele
                                       Chief Executive Officer




                                       /s/   Gailen J. Hull
                                       ------------------------------
                                       Gailen J. Hull
                                       Chief Financial Officer and
                                       Principal Accounting Officer
# C_2015354EN.01003801.xml

| 26.10.2015 | EN | Official Journal of the European Union | C 354/38 |
| --- | --- | --- | --- |

26.10.2015

EN

Official Journal of the European Union

C 354/38

---

Judgment of the General Court of 10 September 2015 — Laverana v OHIM (ORGANIC PROTEIN RICH PLANT COMPLEX FROM OUR OWN PRODUCTION)

(Case T-609/14) (1)

1

((Community trade mark - Application for Community figurative mark ORGANIC PROTEIN RICH PLANT COMPLEX FROM OUR OWN PRODUCTION - Absolute ground for refusal - Descriptive character - Article 7(1)(c) of Regulation (EC) No 207/2009))

(2015/C 354/45)

Language of the case: German

Parties

Parties

Applicant: Laverana GmbH & Co. KG (Wennigsen, Germany) (represented by: J. Wachinger, M. Zöbisch and D. Chatterjee, lawyers)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: D. Walicka and D. Botis, acting as Agents)

Defendant:

Re:

Re:

Action brought against the decision of the Fourth Board of Appeal of OHIM of 2 June 2014 (Case R 123/2014-4) concerning an application for registration of the figurative sign ORGANIC PROTEIN RICH PLANT COMPLEX FROM OUR OWN PRODUCTION as a Community trade mark.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Laverana GmbH & Co. KG to bear the costs. |
| --- | --- |

2.

Orders Laverana GmbH & Co. KG to bear the costs.

---

(1)  OJ C 361, 13.10.2014.

1

---
EX-32
       SECTION 1350 CERTIFICATION OF EDWARD H. WEBB

                    SECTION 1350 CERTIFICATION

In connection with the quarterly report of W-J International,
Ltd. ("Company") on Form 10-QSB for the quarter ended March 31, 2004
as filed with the Securities and Exchange Commission ("Report"), the
undersigned, in the capacity and on the date indicated below, hereby
certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(18 U.S.C. Section 1350) that to his knowledge:

1.  The Report fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

2.  The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations
of the Company.


Dated: May 11, 2004                    By: /s/  Edward H. Webb
                                       Edward H. Webb, President
§ 582.5634 Potassium iodide. ( a ) *Product.* Potassium iodide.
( b ) *Tolerance.* 0.01 percent.
( c ) *Limitations, restrictions, or explanation.* This substance is generally recognized as safe when used in table salt as a source of dietary iodine in accordance with good manufacturing or feeding practice.
[Federal Register Volume 75, Number 41 (Wednesday, March 3, 2010)]
[Notices]
[Page 9606]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4433]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Public Health Research on Craniofacial 
Malformation, Funding Opportunity Announcement (FOA) DP 10-001, Initial 
Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 11 a.m.-5 p.m., April 22, 2010 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Public Health Research on Craniofacial Malformation, 
FOA DP 10-001.''
    Contact Person for More Information: Michael Dalmat, DrPH, 
Scientific Review Officer, National Center for Chronic Disease and 
Health Promotion, Office of the Director, Extramural Research 
Program Office, 4770 Buford Highway, NE., Mailstop K-92, Atlanta, GA 
30341, Telephone: (770) 488-6423, E-mail: <a href="/cdn-cgi/l/email-protection#bef3fbfa8ffedddadd90d9d1c8"><span class="__cf_email__" data-cfemail="f0bdb5b4c1b0939493de979f86">[email protected]</span></a>.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: February 24, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-4433 Filed 3-2-10; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
§ 814.122 Confidentiality of data and information. ( a ) *Requirement for disclosure.* The “HDE file” includes all data and information submitted with or referenced in the HDE, any IDE incorporated into the HDE, any HDE amendment or supplement, any report submitted under § 814.126, any master file, or any other related submission. Any record in the HDE file will be available for public disclosure in accordance with the provisions of this section and part 20 of this chapter.
( b ) *Extent of disclosure.* Disclosure by FDA of the existence and contents of an HDE file shall be subject to the same rules that pertain to PMA's under § 814.9(b) through (h), as applicable.
* Pursuant to 5 TH C IR . R. 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 97-41082 Summary Calendar

THEODORE FLANAGAN, Plaintiff-Appellant,

versus NACOGDOCHES COUNTY JAIL, In its capacity as an institution of confinement; Et Al, Defendants, NACOGDOCHES COUNTY JAIL, In its capacity as an institution of confinement; JOE EVANS, In his official capacity as Sheriff, Nacogdoches, Texas; MOLLY BROWN; RODNEY WHITAKE; GINGER HENSON, Defendants-Appellees.

- - - - - - - - - - Appeal from the United States District Court for the Eastern District of Texas USDC No. 9:95-CV-233

- - - - - - - - - - July 29, 1998 Before EMILIO M. GARZA, DeMOSS and BENAVIDES, Circuit Judges.
PER CURIAM: * Theodore Flanagan, Texas prisoner # 734335, appeals the dismissal of his suit pursuant to 28 U.S.C. § 1915(e). FlanaganNo. 97-41082 -2- contends that he was denied medical care, the recreational yard is unsafe, and he has been retaliated against for filing a grievance. We have reviewed the record and Flanagan’s brief and AFFIRM the district court’s dismissal for essentially the same reasons adopted by the district court. Flanagan v. Nacogdoches County Jail , No. 9:95-CV-233 (Aug. 11, 1995).
AFFIRMED.
# C_2015389EN.01005201.xml

| 23.11.2015 | EN | Official Journal of the European Union | C 389/52 |
| --- | --- | --- | --- |

23.11.2015

EN

Official Journal of the European Union

C 389/52

---

Judgment of the General Court of 23 September 2015 — Mechadyne International v OHIM (FlexValve)

(Case T-588/14) (1)

1

((Community trade mark - Application for a Community figurative mark FlexValve - Absolute grounds for refusal - Descriptive character - Lack of distinctive character - Article 7(1)(b) and (c) of Regulation (EC) No 207/2009 - Rights of the defence - Duty to state reasons - Article 75 of Regulation No 207/2009))

(2015/C 389/58)

Language of the case: German

Parties

Parties

Applicant: Mechadyne International Ltd (Kirtlington, United Kingdom) (represented by S. von Petersdorff-Campen and E. Schaper, lawyers)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented initially by A. Pohlmann, then S. Hanne, acting as Agents)

Defendant:

Re:

Re:

Action brought against the decision of the Fourth Board of Appeal of OHIM of 3 June 2014 (Case R 2435/2013-4), concerning an application for registration of the figurative sign FlexValve as a Community trade mark.

Operative part of the judgment

Operative part of the judgment

The Court

| 1) | Dismisses the action; |
| --- | --- |

1)

Dismisses the action;

| 2) | Orders Mechadyne International Ltd to pay the costs. |
| --- | --- |

2)

Orders Mechadyne International Ltd to pay the costs.

---

(1)  OJ C 361, 13.10.2014.

1

---
# C_2016059EN.01001701.xml

| 15.2.2016 | EN | Official Journal of the European Union | C 59/17 |
| --- | --- | --- | --- |

15.2.2016

EN

Official Journal of the European Union

C 59/17

---

Judgment of the General Court of 17 December 2015 — Bice International v OHIM — Bice (bice)

(Case T-624/14) (1)

1

((Community trade mark - Invalidity proceedings - Community word mark bice - Ealier national figurative mark 1926 BiCE RISTORANTE - No genuine use of the earlier mark - Article 57(2) and (3) of Regulation No 207/2009))

(2016/C 059/17)

Language of the case: German

Parties

Parties

Applicant: Bice International Ltd (Dubai, United Arab Emirates) (represented initially by N. Gibb, Solicitor, and D. McFarland, Barrister, and subsequently by D. McFarland)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: M. Fischer, acting as Agent)

Defendant:

Other party to the proceedings before the Board of Appeal of OHIM, intervener before the General Court: Bice AG (Baar, Switzerland) (represented by: D. Pauli, lawyer)

Other party to the proceedings before the Board of Appeal of OHIM, intervener before the General Court:

Re:

Re:

Action brought against the decision of the First Board of Appeal of OHIM of 23 May 2014 (Case R 1249/2013-1), relating to invalidity proceedings between Bice International Ltd and Bice AG.

Operative part of the judgment

Operative part of the judgment

| 1) | The action is dismissed. |
| --- | --- |

1)

The action is dismissed.

| 2) | Bice International Ltd shall bear the costs. |
| --- | --- |

2)

Bice International Ltd shall bear the costs.

---

(1)  OJ C 351, 6.10.2014.

1

---
#### § 81.1 Provisional lists of color additives.

The Commissioner of Food and Drugs finds that the following lists of color additives are provisionally listed under section 203(b) of the Color Additive Amendments of 1960 (sec. 203(b), 74 Stat. 405 ([21 U.S.C. 379e note](https://www.govinfo.gov/link/uscode/21/379e))). Except for color additives for which petitions have been filed, progress reports are required by January 1, 1968, and at 6-month intervals thereafter. Specifications for color additives listed in [paragraphs (a)](/on/2024-09-17/title-21/section-81.1#p-81.1(a)), [(b)](/on/2024-09-17/title-21/section-81.1#p-81.1(b)), and [(c)](/on/2024-09-17/title-21/section-81.1#p-81.1(c)) of this section appear in the respective designated sections. The listing of color additives in this section is not to be construed as a listing for surgical suture use unless color additive petitions have been submitted for such use or the Commissioner has been notified of studies underway to establish the safety of the color additive for such use. The color additives listed in [paragraphs (a)](/on/2024-09-17/title-21/section-81.1#p-81.1(a)), [(b)](/on/2024-09-17/title-21/section-81.1#p-81.1(b)), and [(c)](/on/2024-09-17/title-21/section-81.1#p-81.1(c)) of this section may not be used in products which are intended to be used in the area of the eye. The color additives listed in [paragraphs (a)](/on/2024-09-17/title-21/section-81.1#p-81.1(a)), [(b)](/on/2024-09-17/title-21/section-81.1#p-81.1(b)), and [(c)](/on/2024-09-17/title-21/section-81.1#p-81.1(c)) of this section are provisionally listed until the closing dates set forth therein.

(a) *Color additives previously and presently subject to certification and provisionally listed for food, drug, and cosmetic use.*

| Color additive | Closing date | | Restrictions |
| --- | --- | --- | --- |
| Food use | Drug and cosmetic use |
| Lakes (FD&C) (sec. 82.51 of this chapter) | | | |

(b) *Color additives previously and presently subject to certification and provisionally listed for drug and cosmetic use.*

| | Closing date | Restrictions |
| --- | --- | --- |
| Lakes (D&C) (Sec. 82.2051 of this chapter) | | |

(c) *Color additives previously and presently subject to certification and provisionally listed for use in externally applied drugs and cosmetics.*

| | Closing date | Restrictions |
| --- | --- | --- |
| Lakes (Ext. D&C) (sec. 82.105(1) of this chapter) | | |

[[42 FR 15665](https://www.federalregister.gov/citation/42-FR-15665), Mar. 22, 1977]

###### Editorial Note

#### Editorial Note:

For Federal Register citations affecting [§ 81.1](/on/2024-09-17/title-21/section-81.1), see the List of CFR Sections Affected, which appears in the Finding Aids section of the printed volume and at *[www.govinfo.gov](http://www.govinfo.gov).*
IN THE SUPREME COURT OF PENNSYLVANIA

WESTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

ANTONIO DION FERGUSON,

Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 358 WAL 2021

Petition for Allowance of Appeal 

from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 22nd day of March, 2022, the Petition for Allowance of Appeal is 

DENIED.
# C_2014431EN.01004901.xml

| 1.12.2014 | EN | Official Journal of the European Union | C 431/49 |
| --- | --- | --- | --- |

1.12.2014

EN

Official Journal of the European Union

C 431/49

---

Action brought on 1 September 2014 — ZZ v Council

(Case F-87/14)

(2014/C 431/78)

Language of the case: French

Parties

Parties

Applicant: ZZ (represented by: M. Velardo, lawyer)

Applicant:

Defendant: Council of the European Union

Defendant:

Subject-matter and description of the proceedings

Subject-matter and description of the proceedings

Action seeking (i) the annulment of the Council’s decisions relating to the reimbursement of the applicant’s hospital expenses and (ii) an order for the Council to pay default and compensatory interest, on the one hand, and compensation for the non-material damage allegedly suffered, on the other.

Form of order sought

Form of order sought

The applicant claims that the Tribunal should:

| — | Partially annul the decisions of the Brussels Settlements Office, as set out in Statement 55 of 27 September 2013, relating to the applicant’s request of 12 July 2012 for reimbursement of hospital expenses; |
| --- | --- |

—

Partially annul the decisions of the Brussels Settlements Office, as set out in Statement 55 of 27 September 2013, relating to the applicant’s request of 12 July 2012 for reimbursement of hospital expenses;

| — | declare that the letters of 19 November 2013 from the Head of the Settlements Office concerning the unfavourable response to a supposed prior authorisation request of 12 July 2012 are invalid, or, in the alternative, annul those letters; |
| --- | --- |

—

declare that the letters of 19 November 2013 from the Head of the Settlements Office concerning the unfavourable response to a supposed prior authorisation request of 12 July 2012 are invalid, or, in the alternative, annul those letters;

| — | annul, so far as is necessary, the appointing authority’s decision of 22 May 2014 rejecting the complaints submitted by the applicant on 27 December 2013 and 18 February 2014; |
| --- | --- |

—

annul, so far as is necessary, the appointing authority’s decision of 22 May 2014 rejecting the complaints submitted by the applicant on 27 December 2013 and 18 February 2014;

| — | order the Council to pay the default and compensatory interest with effect from the date on which the sums claimed were payable, and to pay compensation for the non-material damage suffered by the applicant; |
| --- | --- |

—

order the Council to pay the default and compensatory interest with effect from the date on which the sums claimed were payable, and to pay compensation for the non-material damage suffered by the applicant;

| — | order the Council to pay the costs. |
| --- | --- |

—

order the Council to pay the costs.

---